業績

2021年業績

欧文原著 - 当研究室の2021年の業績です。

  1. Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome-Associated Lung Adenocarcinoma.
    Masuzawa K, Asakura T, Ikemura S, Yasuda H, Kawada I, Takaoka S, Hayashi Y, Nakajima T, Arai M, Fukunaga K, Soejima K.
    JCO Precis Oncol. 2021 Feb 14;4:PO.19.00156. doi: 10.1200/PO.19.00156. eCollection 2020.
  2. The real-time reverse transcription-polymerase chain reaction threshold cycle values for severe acute respiratory syndrome coronavirus 2 predict the prognosis of coronavirus disease 2019 pneumonia.
    Fukushima T, Kabata H, Yamamoto R, Suhara T, Uwamino Y, Kondo Y, Masaki K, Kamata H, Nagata H, Homma K, Kaneko Y, Ishii M, Sasaki J, Morisaki H, Hasegawa N, Fukunaga K; Keio Donner Project Team.
    Respir Investig. 2021 Jan 28;S2212-5345(21)00008-3. doi: 10.1016/j.resinv.2020.12.011. Online ahead of print.
  3. The effect of statins for asthma. A systematic review and meta-analysis.
    Sunata K, Kabata H, Kuno T, Takagi H, So M, Masaki K, Fukunaga K.
    J Asthma. 2021 Feb 16:1-10. doi: 10.1080/02770903.2021.1879850. Online ahead of print.
  4. Bilateral pneumothorax after acupuncture treatment.
    Nishie M, Masaki K, Kayama Y, Yoshino T.
    BMJ Case Rep. 2021 Mar 1;14(3):e241510. doi: 10.1136/bcr-2020-241510.
  5. The product of trunk muscle area and density on the CT image is a good indicator of energy expenditure in patients with or at risk for COPD.
    Shirahata T, Sato H, Yogi S, Inoue K, Niitsu M, Akagami T, Soma M, Mio T, Nagata M, Nakae S, Nishida Y, Tanaka S, Katsukawa F, Nakamura H.
    Respir Res. 2021 Jan 15;22(1):18. doi: 10.1186/s12931-021-01621-2.
  6. Video-assisted thoracic surgery for a case of chronic progressive pulmonary aspergillosis undergoing haemodialysis complicated by anorexia nervosa: a case report.
    Shirahata T, Akimoto M, Minegishi K, Endo S, Nakamura H, Nagata M.
    Respirol Case Rep. 2021 Feb 22;9(4):e00727. doi: 10.1002/rcr2.727. eCollection 2021 Apr.
  7. Clinical Features and Prognosis of Nontuberculous Mycobacterial Pleuritis: A Multicenter Retrospective Study.
    Yagi K, Ito A, Fujiwara K, Morino E, Hase I, Nakano Y, Asakura T, Furuuchi K, Morita A, Asami T, Namkoong H, Saito F, Morimoto K, Ishii M, Sato Y, Tateno H, Nishio K, Oyamada Y, Fukunaga K, Sugiyama H, Ishida T, Kurashima A, Hasegawa N; Nontuberculous mycobacteriosis and bronchiectasis- Japan Research Consortium (NTM-JRC).
    Ann Am Thorac Soc. 2021 Apr 8. doi: 10.1513/AnnalsATS.202008-938OC. Online ahead of print.
  8. PD-L2 suppresses T cell signaling via coinhibitory microcluster formation and SHP2 phosphatase recruitment.
    Takehara T, Wakamatsu E, Machiyama H, Nishi W, Emoto K, Azuma M, Soejima K, Fukunaga K, Yokosuka T.
    Commun Biol. 2021 May 14;4(1):581. doi: 10.1038/s42003-021-02111-3.
  9. Differences in airway lumen area　between supine and upright computed　tomography in patients with chronic obstructive pulmonary disease.
    Chubachi S, Yamada Y, Yamada M, Yokoyama Y, Tanabe A, Matsuoka S, Niijima Y, Yamasawa W, Irie H, Murata M, Fukunaga K, Jinzaki M.
    Respir Res. 2021 Mar 31;22(1):95. doi: 10.1186/s12931-021-01692-1.
  10. Eosinophilic annular erythema showing eosinophil cytolytic ETosis successfully treated with benralizumab.
    Masaki K, Ueki S, Tanese K, Nagao G, Kanzaki S, Matsuki E, Irie H, Kabata H, Miyata J, Kawada I, Fukunaga K.
    Asia Pac Allergy. 2021 Jul 12;11(3):e28. doi: 10.5415/apallergy.2021.11.e28. eCollection 2021 Jul.
  11. Successful treatment of a patient with adult food allergy and severe asthma using omalizumab.
    Nishie M, Masaki K, Okuzumi S, Mochimaru T, Kabata H, Miyata J, Takahashi H, Fukunaga K.
    Asia Pac Allergy. 2021 Jul 9;11(3):e27. doi: 10.5415/apallergy.2021.11.e27. eCollection 2021 Jul.
  12. SHOC2 Is a Critical Modulator of Sensitivity to EGFR-TKIs in Non-Small Cell Lung Cancer Cells.
    Terai H, Hamamoto J, Emoto K, Masuda T, Manabe T, Kuronuma S, Kobayashi K, Masuzawa K, Ikemura S, Nakayama S, Kawada I, Suzuki Y, Takeuchi O, Suzuki Y, Ohtsuki S, Yasuda H, Soejima K, Fukunaga K.
    Mol Cancer Res. 2021 Feb;19(2):317-328. doi: 10.1158/1541-7786.MCR-20-0664. Epub 2020 Oct 26.
  13. Platinum-doublet chemotherapy as second-line treatment for relapsed patients with small-cell lung cancer: A systematic review and meta-analysis.
    Horiuchi K, Sato T, Kuno T, Takagi H, Hirsch FR, Powell CA, Fukunaga K.
    Lung Cancer. 2021 Jun;156:59-67. doi: 10.1016/j.lungcan.2021.04.013. Epub 2021 Apr 19.
  14. Characteristics of chronic obstructive pulmonary disease patients with robust progression of emphysematous change.
    Tsutsumi A, Chubachi S, Irie H, Sasaki M, Yamada Y, Sugiura H, Jinzaki M, Nakamura H, Asano K, Betsuyaku T, Fukunaga K.
    Sci Rep. 2021 May 5;11(1):9548. doi: 10.1038/s41598-021-87724-8.
  15. TLR7 Agonist Suppresses Group 2 Innate Lymphoid Cell-mediated Inflammation via IL-27-Producing Interstitial Macrophages.
    Okuzumi S, Miyata J, Kabata H, Mochimaru T, Kagawa S, Masaki K, Irie M, Morita H, Fukunaga K.
    Am J Respir Cell Mol Biol. 2021 Sep;65(3):309-318. doi: 10.1165/rcmb.2021-0042OC.
  16. Direct derivation of human alveolospheres for SARS-CoV-2 infection modeling and drug screening.
    Ebisudani T, Sugimoto S, Haga K, Mitsuishi A, Takai-Todaka R, Fujii M, Toshimitsu K, Hamamoto J, Sugihara K, Hishida T, Asamura H, Fukunaga K, Yasuda H, Katayama K, Sato T.
    Cell Rep. 2021 Jun 8;35(10):109218. doi: 10.1016/j.celrep.2021.109218. Epub 2021 May 19.
  17. Upregulation of FGF9 in Lung Adenocarcinoma Transdifferentiation to Small Cell Lung Cancer.
    Ishioka K, Yasuda H, Hamamoto J, Terai H, Emoto K, Kim TJ, Hirose S, Kamatani T, Mimaki S, Arai D, Ohgino K, Tani T, Masuzawa K, Manabe T, Shinozaki T, Mitsuishi A, Ebisudani T, Fukushima T, Ozaki M, Ikemura S, Kawada I, Naoki K, Nakamura M, Ohtsuka T, Asamura H, Tsuchihara K, Hayashi Y, Hegab AE, Kobayashi SS, Kohno T, Watanabe H, Ornitz DM, Betsuyaku T, Soejima K, Fukunaga K.
    Cancer Res. 2021 Jul 15;81(14):3916-3929. doi: 10.1158/0008-5472.CAN-20-4048. Epub 2021 Jun 3.
  18. A rare case of COVID-19 infection with laryngeal involvement.
    Asaoka M, Chubachi S, Yamada Y, Fukunaga K.
    BMJ Case Rep. 2021 Jun 4;14(6):e242426. doi: 10.1136/bcr-2021-242426.
  19. 12/15-Lipoxygenase Regulates IL-33-Induced Eosinophilic Airway Inflammation in Mice.
    Miyata J, Yokokura Y, Moro K, Arai H, Fukunaga K, Arita M.
    Front Immunol. 2021 May 19;12:687192. doi: 10.3389/fimmu.2021.687192. eCollection 2021.
  20. Longitudinal validity and prognostic significance of the St George's Respiratory Questionnaire in Mycobacterium avium complex pulmonary disease.
    Ogawa T, Asakura T, Suzuki S, Okamori S, Kusumoto T, Sato Y, Namkoong H, Kamata H, Ishii M, Fukunaga K, Hasegawa N.
    Respir Med. 2021 Aug-Sep;185:106515. doi: 10.1016/j.rmed.2021.106515. Epub 2021 Jun 18.
  21. Effect of High Fat Diet on the Severity and Repair of Lung Fibrosis in Mice.
    Hegab AE, Ozaki M, Kagawa S, Fukunaga K.
    Stem Cells Dev. 2021 Sep 15;30(18):908-921. doi: 10.1089/scd.2021.0050. Epub 2021 Aug 24.
  22. Thymoma-associated T-cell immunodeficiency after radiotherapy: A case report.
    Nakagawara K, Chubachi S, Azekawa S, Otake S, Saito A, Okada M, Lee K, Masaki K, Koike N, Kamata H, Kawada I, Suzuki S, Ishii M, Fukunaga K.
    Respir Med Case Rep. 2021 Apr 2;33:101408. doi: 10.1016/j.rmcr.2021.101408. eCollection 2021.
  23. Longitudinal Assessment of Prognostic Understanding in Patients with Advanced Lung Cancer and Its Association with Their Psychological Distress.
    Arai D, Sato T, Nakachi I, Fujisawa D, Takeuchi M, Sato Y, Kawada I, Yasuda H, Ikemura S, Terai H, Nukaga S, Inoue T, Nakamura M, Oyamada Y, Terashima T, Sayama K, Saito F, Sakamaki F, Naoki K, Fukunaga K, Soejima K.
    Oncologist. 2021 Dec;26(12):e2265-e2273. doi: 10.1002/onco.13973. Epub 2021 Sep 23.
  24. ADAM10 partially protects mice against influenza pneumonia by suppressing specific myeloid cell population.
    Okamori S, Ishii M, Asakura T, Suzuki S, Namkoong H, Kagawa S, Hegab AE, Yagi K, Kamata H, Kusumoto T, Ogawa T, Takahashi H, Yoda M, Horiuchi K, Hasegawa N, Fukunaga K.
    Am J Physiol Lung Cell Mol Physiol. 2021 Nov 1;321(5):L872-L884. doi: 10.1152/ajplung.00619.2020. Epub 2021 Sep 15.
  25. Clinical Characteristics of Patients with Coronavirus Disease (COVID-19): Preliminary Baseline Report of Japan COVID-19 Task Force, a Nationwide Consortium to Investigate Host Genetics of COVID-19.
    Tanaka H, Lee H, Morita A, Namkoong H, Chubachi S, Kabata H, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y, Tokunaga K, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; Japan COVID-19 Task Force.
    Int J Infect Dis. 2021 Dec;113:74-81. doi: 10.1016/j.ijid.2021.09.070. Epub 2021 Sep 30.
  26. Clinical Characteristics and Therapeutic Outcomes of Metastatic Peritoneal Carcinomatosis in Non-Small-Cell Lung Cancer.
    Tani T, Nakachi I, Ikemura S, Nukaga S, Ohgino K, Kuroda A, Terai H, Masuzawa K, Shinozaki T, Ishioka K, Funatsu Y, Koh H, Fukunaga K, Soejima K; Keio Lung Oncology Group (KLOG).
    Cancer Manag Res. 2021 Sep 29;13:7497-7503. doi: 10.2147/CMAR.S330103. eCollection 2021.
  27. Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol.
    Nakagawara K, Namkoong H, Terai H, Masaki K, Tanosaki T, Shimamoto K, Lee H, Tanaka H, Okamori S, Kabata H, Chubachi S, Ikemura S, Kamata H, Yasuda H, Kawada I, Ishii M, Ishibashi Y, Harada S, Fujita T, Ito D, Bun S, Tabuchi H, Kanzaki S, Shimizu E, Fukuda K, Yamagami J, Kobayashi K, Hirano T, Inoue T, Kagyo J, Shiomi T, Ohgino K, Sayama K, Otsuka K, Miyao N, Odani T, Oyamada Y, Masuzawa K, Nakayama S, Suzuki Y, Baba R, Nakachi I, Kuwahara N, Ishiguro T, Mashimo S, Minematsu N, Ueda S, Manabe T, Funatsu Y, Koh H, Yoshiyama T, Saito F, Ishioka K, Takahashi S, Nakamura M, Goto A, Harada N, Kusaka Y, Nakano Y, Nishio K, Tateno H, Edahiro R, Takeda Y, Kumanogoh A, Kodama N, Okamoto M, Umeda A, Hagimura K, Sato T, Miyazaki N, Takemura R, Sato Y, Takebayashi T, Nakahara J, Mimura M, Ogawa K, Shimmura S, Negishi K, Tsubota K, Amagai M, Goto R, Ibuka Y, Hasegawa N, Kitagawa Y, Kanai T, Fukunaga K.
    BMJ Open Respir Res. 2021 Nov;8(1):e001015. doi: 10.1136/bmjresp-2021-001015.
  28. [PATHOPHYSIOLOGY AND TREATMENT OF ASTHMA IN PATIENTS WITH EOSINOPHILIC RHINOSINUSITIS AND OTITIS MEDIA].
    Fukunaga K, Miyata J.
    Arerugi. 2021;70(10):1343-1349. doi: 10.15036/arerugi.70.1343.

業績一覧へ戻る

トピックス